www.medicinapropraxi.cz 280 MEDICÍNA PRO PRAXI / Med. Praxi. 2024;21(5):276-280 / PŘEHLEDOVÉ ČLÁNKY Imunopatogeneze diabetu mellitu 1. typu – pohled pro klinickou praxi system. Clin J Am Soc Nephrol. 2015;10(7):1274-81. 4. Zhu X, Zhu J. CD4 T Helper Cell Subsets and Related Human Immunological Disorders. Int J Mol Sci. 2020;21(21):8011. Published 2020 Oct 28. doi:10.3390/ijms21218011. 5. Thompson PJ, Pipella J, Rutter GA et al. Islet autoimmunity in human type 1 diabetes: initiation and progression from the perspective of the beta cell. Diabetologia. 2023;66(11):1971-82. 6. Ziegler AG, Hillebrand B, Rabl W, et al. On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth. Diabetologia. 1993;36(5):402-8. 7. Ziegler AG. The countdown to type 1 diabetes: when, how and why does the clock start? Diabetologia. 2023;66(7):1169-78. 8. Arif S, Moore F, Marks K, et al. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death. Diabetes. 2011;60(8):2112-19. 9. Sharp SA, Rich SS, Wood AR, et al. Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis. Diabetes Care. 2019;42(2):200-7. 10. Lemos JRN, Hirani K, von Herrath M. Immunological and virological triggers of type 1 diabetes: insights and implications. Front Immunol. 2024;14:1326711. Published 2024 Jan 4. doi:10.3389/fimmu.2023.1326711. 11. Kashfi K, Anbardar N, Asadipooya A, et al. Type 1 Diabetes and COVID-19: A Literature Review and Possible Management. Int J Endocrinol Metab. 2023;21(4):e139768. Published 2023 Oct 23. doi:10.5812/ijem-139768. 12. Krogvold L, Mynarek IM, Ponzi E, et al. Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial. Nat Med. 2023;29(11):2902-08. 13. Writing Group for the TRIGR Study Group, Knip M, Åkerblom HK, et al. Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial. JAMA. 2018;319(1):38-48. 14. Pracovní skupina Ministerstva zdravotnictví pro výživu dětí Doporučení k zavádění komplementární výživy (příkrmu) u kojenců. [2024-08-01] Available from: https://mzd.gov.cz/doporuceni-k-zavadeni-komplementarni-vyzivy-prikrmuu-kojencu/. 15. Cardwell CR, Stene LC, Joner G, et al. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia. 2008;51:726-735. 16. Battaglia M, Ahmed S, Anderson MS, et al. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes. Diabetes Care. 2020 Jan;43(1):5-12. 17. Mameli C, Triolo TM, Chiarelli F, et al. Lessons and gaps in the prediction and prevention of type 1 diabetes. Pharmacol Res. 2023;193:106792. doi:10.1016/j.phrs.2023.106792. 18. Ziegler AG, Kick K, Bonifacio E, et al. Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany. JAMA. 2020;323(4):339-51. 19. Karl FM, Winkler C, Ziegler AG, et al. Costs of Public Health Screening of Children for Presymptomatic Type 1 Diabetes in Bavaria, Germany. Diabetes Care. 2022;45(4):837-44. 20. Herold KC, Gitelman SE, Gottlieb PA, et al. Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function. Diabetes Care. 2023;46(10):1848-56. 21. Projekt βetty. [2024-08-01] Available from: https://projektbetty.cz/. Tip na dárek pro zdravotníky Potěšte své přátele a blízké z řad lékařů či farmaceutů předplatným některého z časopisů vydavatelství SOLEN. ◼ ČESKÁ A SLOVENSKÁ FARMACIE ◼ DERMATOLOGIE PRO PRAXI ◼ MEDICÍNA PRO PRAXI ◼ NEUROLOGIE PRO PRAXI ◼ ONKOLOGIE ◼ PEDIATRIE PRO PRAXI ◼ PSYCHIATRIE PRO PRAXI ◼ UROLOGIE PRO PRAXI ◼ VNITŘNÍ LÉKAŘSTVÍ Pro obdarovaného si vytisknete dárkový certi kát. DÁRKOVÝ POUKAZ NA ROČNÍ PŘEDPLATNÉ ČASOPISU MEDICÍNA PRO PRAXI www.medicinapropraxi.cz https://www.solen.cz/artkey/inf-990001-2800.php NÁVOD, JAK POSTUPOVAT
RkJQdWJsaXNoZXIy NDA4Mjc=